* IRadimed Corp IRMD.OQ reported quarterly adjusted
earnings of
36 cents per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for earnings
of 31 cents per share.
* Revenue rose 26.8% to $16.13 million from a year ago;
analysts
expected $15.65 million.
* IRadimed Corp's reported EPS for the quarter was 33
cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* IRadimed Corp shares had fallen by 8.4% this quarter and
gained 59.3% so far this year.
* The company reported quarterly net income of $4.18
million.
* Wall Street's median 12-month price target for IRadimed
Corp is
$55.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 3 at 02:19 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 0.31 0.36 Beat
Mar. 31 2023 0.28 0.30 Beat
Dec. 31 2022 0.30 0.32 Beat
Sep. 30 2022 0.25 0.29 Beat